Toll-like receptors in ocular surface disease

Experimental Eye Research

Volumn 90, Issue 6, 2010, Pages 679-687

  Redfern, Rachel L ^a   McDermott, Alison M ^a  

^a UNIVERSITY OF HOUSTON   (United States)

Author keywords

Conjunctiva; Cornea; Infection; Inflammation; Toll like receptors

Indexed keywords

BETA DEFENSIN 2; BETA INTERFERON; FLAGELLIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; INTERLEUKIN 8; MITOGEN ACTIVATED PROTEIN KINASE; MYELOID DIFFERENTIATION FACTOR 88; STRESS ACTIVATED PROTEIN KINASE; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 10; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR ALPHA;

ADAPTIVE IMMUNITY; ALLERGIC CONJUNCTIVITIS; ARTICLE; ATOPIC KERATOCONJUNCTIVITIS; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DRY EYE; EYE DISEASE; HERPES SIMPLEX KERATITIS; HUMAN; INNATE IMMUNITY; KERATITIS; KERATOMYCOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; VERNAL CONJUNCTIVITIS; ANIMAL; BACTERIAL EYE INFECTION; CONJUNCTIVA; CORNEA; CORNEA ULCER; METABOLISM; REVIEW; SJOEGREN SYNDROME;

ANIMALS; CONJUNCTIVA; CONJUNCTIVITIS, ALLERGIC; CORNEA; CORNEAL ULCER; EYE INFECTIONS, BACTERIAL; HUMANS; SJOGREN'S SYNDROME; TOLL-LIKE RECEPTORS;

EID: 77952769522     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exer.2010.03.012     Document Type: Review

References (107)

1. 2 terminal kinase (JNK) is an essential mediator of toll-like receptor 2-induced corneal inflammation. J. Leukoc. Biol. 2008, 83:991-997.
2. Afonso A.A., Obrin L., Monroy D.C., et al. Tear fluid gelatinase B activity correlates with IL-1alpha concentration and fluorescein clearance in ocular rosacea. Invest. Ophthalmol. Vis. Sci. 1999, 40:2506-2512.
3. Albiger B., Dahlberg S., Henriques-Normark B., et al. Role of the innate immune system in host defense against bacterial infections: focus on toll-like receptors. J. Intern. Med. 2007, 261:511-528.
4. Alexopoulou L., Holt A.C., Medzhitov R., et al. Recognition of double-stranded RNA and activation of NF-kappaB by toll-like receptor 3. Nature 2001, 413:732-738.
5. Barabino S., Rolando M., Bonini S., et al. Toll-like receptor (TLR) 2 and TLR4 expression in dry eye. Invest. Ophthalmol. Vis. Sci. 2006, 47. E-Abstract 5594.
6. Bauer S., Hangel D., Yu P. Immunobiology of toll-like receptors in allergic disease. Immunobiology 2007, 212:521-533.
7. Begon E., Michel L., Flageul B., et al. Expression, subcellular localization and cytokinic modulation of toll-like receptors (TLRs) in normal human keratinocytes: TLR2 up-regulation in psoriatic skin. Eur. J. Dermatol. 2007, 17:497-506.
8. Berra A., Dutt J.E., Nouri M., Foster C.S. Heat shock protein expression in human conjunctiva. Invest. Ophthalmol. Vis. Sci. 1994, 35:352-357.
9. Beutler B. TLR4: central component of the sole mammalian LPS sensor. Curr. Opin. Immunol. 2000, 12:20-26.
10. Blais D.R., Vascotto S.G., Griffith M., et al. LBP and CD14 secreted in tears by the lacrimal glands modulate the LPS response of corneal epithelial cells. Invest. Ophthalmol. Vis. Sci. 2005, 46:4235-4244.
11. Bonini S., Micera A., Iovieno A., et al. Expression of toll-like receptors in healthy and allergic conjunctiva. Ophthalmology 2005, 112:1528-1534.
12. Bourcier T., Thomas F., Borderie V., Chaumeil C., Laroche L. Bacterial keratitis: predisposing factors, clinical and microbiological review of 300 cases. Br. J. Ophthalmol. 2003, 87:834-838.
13. Bron A.J., Tiffany J.M., Yokoi N., et al. Using osmolarity to diagnose dry eye: a compartmental hypothesis and review of our assumptions. Adv. Exp. Med. Biol. 2002, 506:1087-1095.
14. Chang D.C., Grant G.B., O'Donnell K., et al. Fusarium Keratitis Investigation Team. Multistate outbreak of Fusarium keratitis associated with use of a contact lens solution. JAMA 2006, 23:953-963.
15. Christopherson P.L., Smith J., Sosne G. Early corneal and lacrimal gene expression of inflammatory genes in a murine model of Sjogren's syndrome. Invest. Ophthalmol. Vis. Sci. 2005, 46. E-Abstract 4462.
16. Chung S.H., Kweon M.N., Lee H.K., Choi S.I., Yang J.Y., Kim E.K. Toll-like receptor 4 initiates an innate immune response to lipopolysaccharide in human conjunctival epithelial cells. Exp. Eye Res. 2009, 88:49-56.
17. Cook E.B., Stahl J.L., Esnault S., et al. Toll-like receptor 2 expression on human conjunctival epithelial cells: a pathway for Staphylococcus aureus involvement in chronic ocular proinflammatory responses. Ann. Allergy Asthma Immunol. 2005, 94:486-497.
18. Cook W.J., Kramer M.F., Walker R.M., et al. Persistent expression of chemokine and chemokine receptor RNAs at primary and latent sites of herpes simplex virus 1 infection. Virol. J. 2004, 1:5.
19. Derk C.T., Vivino F.B. A primary care approach to Sjögren's syndrome. Helping patients cope with sicca symptoms. Postgrad. Med. 2004, 116:49-54.
20. Diebold S.S., Kaisho T., Hemmi H., et al. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 2004, 303:1529-1531.
21. Ebihara N., Yamagami S., Chen L., et al. Expression and function of toll-like receptor-3 and -9 in human corneal myofibroblasts. Invest. Ophthalmol. Vis. Sci. 2007, 48:3069-3076.
22. Eisenbarth S.C., Piggott D.A., Huleatt J.W., et al. Lipopolysaccharide enhanced, toll-like receptor 4-dependent T helper cell type 2 responses to inhaled antigen. J. Exp. Med. 2002, 196:1645-1651.
23. Farris R.L. Tear osmolarity - a new gold standard?. Adv. Exp. Med. Biol. 1994, 350:495-503.
24. Freidlin J., Acharya N., Lietman T.M., Cevallos V., Whitcher J.P., Margolis T.P. Spectrum of eye disease caused by methicillin-resistant Staphylococcus aureus. Am. J. Ophthalmol. 2007, 144:313-315.
25. Fukushima A., Yamaguchi T., Ishida W., et al. TLR2 agonist ameliorates murine experimental allergic conjunctivitis by inducing CD4 positive T-cell apoptosis rather than by affecting the Th1/Th2 balance. Biochem. Biophys. Res. Commun. 2006, 339:1048-1055.
26. Furlanetto R., Andreo E.G., Finotti I.G., Arcieri E.S., Ferreira M.A., Rocha F.J. Epidemiology and etiologic diagnosis of infectious keratitis in Uberlandia, Brazil. Eur. J. Ophthalmol. 2010, Feb 20.
27. Gilbard J.P., Farris R.L., Santamaria J. Osmolarity of tear microvolumes in keratoconjunctivitis sicca. Arch. Ophthalmol. 1978, 96:677-681.
28. Girgis D.O., Sloop G.D., Reed J.M., O'Callaghan R.J. A new topical model of Staphylococcus corneal infection in the mouse. Invest. Ophthalmol. Vis. Sci. 2003, 44:1591-1597.
29. Gottenberg J.E., Cagnard N., Lucchesi C., et al. Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjögren's syndrome. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:2770-2775.
30. Green M., Apel A., Stapleton F. Risk factors and causative organisms in microbial keratitis. Cornea 2008, 27:22-27.
31. Guo H., Wu X. Innate responses of corneal epithelial cells against Aspergillus fumigatus challenge. FEMS Immunol. Med. Microbiol. 2009, 56:88-93.
32. Hamrah P., Dana M.R. Corneal-antigen presenting cells. Chem. Immunol. Allergy 2007, 92:58-70.
33. Hasan U., Chaffols C., Gaillard C., et al. Human TLR10 is a functional receptor, expressed by B cells and plasmacytoid dendritic cells, which activates gene transcription through MyD88. J. Immunol. 2005, 174:2942-2950.
34. Hayashi F., Smith K.D., Ozinsky A., et al. The innate immune response to bacterial flagellin is mediated by toll-like receptor 5. Nature 2001, 410:1099-1103.
35. Hayashi T., Raz E. TLR9-based immunotherapy for allergic disease. Am. J. Med. 2006, 119:897.e1-897.e6.
36. Hazlett L.D. Corneal response to Pseudomonas aeruginosa infection. Prog. Retin. Eye Res. 2004, 23:1-30.
37. Heil F., Hemmi H., Hochrein H., et al. Species-specific recognition of single-stranded RNA. Science 2004, 303:1526-1529.
38. Hemmi H., Takeuchi O., Kawai T., et al. A toll-like receptor recognizes bacterial DNA. Nature 2000, 408:740-745.
39. Hozono Y., Ueta M., Hamuro J., et al. Human corneal epithelial cells responds to ocular-pathogenic, but not to nonpathogenic-flagellin. Biochem. Biophys. Res. Commun. 2006, 347:238-247.
40. Huang X., Barrett R.P., McClellan S.A., et al. Silencing toll-like receptor-9 in Pseudomonas aeruginosa keratitis. Invest. Ophthalmol. Vis. Sci. 2005, 46:4209-4216.
41. Huang X., Du W., McClellan S.A., et al. TLR4 is required for host resistance in Pseudomonas aeruginosa keratitis. Invest. Ophthalmol. Vis. Sci. 2006, 47:4910-4916.
42. Huang X., Hazlett L.D., Du W., et al. SIGIRR promotes resistance against Pseudomonas aeruginosa keratitis by down-regulating type-1 immunity and IL-1R and TLR4 signaling. J. Immunol. 2006, 177:548-556.
43. Huang L.C., Reins R.Y., Gallo R.L., McDermott A.M. Cathelicidin-deficient (Cnlp-/-) mice show increased susceptibility to Pseudomonas aeruginosa keratitis. Invest. Ophthalmol. Vis. Sci. 2007, 48:4498-4508.
44. Huang X., Du W., Barrett R.P., et al. ST2 is essential for TH2 responsiveness and resistance to Pseudomonas aeruginosa keratitis. Invest. Ophthalmol. Vis. Sci. 2007, 48:4626-4633.
45. Hume E.B., Cole N., Khan S., Garthwaite L.L., Aliwarga Y., Schubert T.L., Willcox M.D. A Staphylococcus aureus mouse keratitis topical infection model: cytokine balance in different strains of mice. Immunol. Cell Biol. 2005, 83:294-300.
46. Hume E.B., Dajcs J.J., Moreau J.M., Sloop G.D., Willcox M.D., O'Callaghan R.J. Staphylococcus corneal virulence in a new topical model of infection. Invest. Ophthalmol. Vis. Sci. 2001, 42:2904-2908.
47. Iyer S.A., Tuli S.S., Wagoner R.C. Fungal keratitis: emerging trends and treatment outcomes. Eye Contact Lens 2006, 32:267-271.
48. Jin X., Qin Q., Chen W., et al. Expression of toll-like receptors in healthy and herpes simplex virus-infected cornea. Cornea 2007, 26:847-852.
49. Jin X., Qin Q., Tu L., Zhou X. Toll-like receptors (TLRs) expression and function in response to inactivate hyphae of Fusarium solani in immortalized human corneal epithelial cells. Mol. Vis. 2007, 13:1953-1961.
50. Jurkunas U., Behlau I., Colby K. Fungal keratitis: changing pathogens and risk factors. Cornea 2009, 28:638-643.
51. Kanzler H., Barrat F.J., Hessel E.M., et al. Therapeutic targeting of innate immunity with toll-like receptor agonists and antagonists. Nat. Med. 2007, 13:552-559.
52. Kerautret J., Raobela L., Colin J. Serious bacterial keratitis: a retrospective clinical and microbiological study. J. Fr. Ophtalmol 2006 Oct, 29(8):883-888.
53. Kawakami A., Nakashima K., Tamai M., et al. Toll-like receptor in salivary glands from patients with Sjögren's syndrome: functional analysis by human salivary gland cell line. J. Rheumatol. 2007, 34:1019-1026.
54. Killedar S.Y., Eckenrode S.E., McIndoe R.A., et al. Early pathogenesis events associated with Sjögren's syndrome (SjS)-like disease of the nod mouse using microarray analysis. Lab. Invest. 2006, 86:1243-1260.
55. Kluwe J., Mencin A., Schwabe R.F. Toll-like receptors, wound healing, and carcinogenesis. J. Mol. Med. 2009, 87:125-138.
56. Kumagai N., Fukuda K., Fujitsu Y., et al. Lipopolysaccharide-induced expression of intercellular adhesion molecule-1 and chemokines in cultured human corneal fibroblasts. Invest. Ophthalmol. Vis. Sci. 2005, 46:114-120.
57. Kumar A., Zhang J., Yu F.-S.X. Innate immune response of corneal epithelial cells to Staphylococcus aureus infection: role of peptidoglycan in stimulating proinflammatory cytokine secretion. Invest. Ophthalmol. Vis. Sci. 2004, 45:3513-3522.
58. Kumar A., Zhang J., Yu F.-S.X. Toll-like receptor 3 agonist poly(I: C)-induced antiviral response in human corneal epithelial cells. Immunology 2006, 117:11-21.
59. Kumar A., Zhang J., Yu F.-S.X. Toll-like receptor 2-mediated expression of β-defensin-2 in human corneal epithelial cells. Microbes Infect. 2006, 8:380-389.
60. Kumar A., Yin J., Zhange J., et al. Modulation of corneal epithelial innate immune response to Pseudomonas infection by flagellin pretreatment. Invest. Ophthalmol. Vis. Sci. 2007, 48:4664-4670.
61. Kumar A., Hazlett L.D., Yu F.S. Flagellin suppresses inflammatory response and enhances bacterial clearance in murine model of Pseudomonas keratitis. Infect. Immun. 2008, 76:89-96.
62. Labetoulle M., Auquier P., Conrad H., et al. Incidence of herpes simplex virus keratitis in France. Ophthalmology 2005, 112:888-895.
63. Lamphier M.S., Sirois C.M., Verma A., et al. TLR9 and the recognition of self and non-self nucleic acids. Ann. N. Y. Acad. Sci. 2006, 1082:31-43.
64. Li D.Q., Luo L., Chen Z., et al. JNK and ERK MAP kinases mediate induction of IL-1beta, TNF-alpha and IL-8 following hyperosmolar stress in human limbal epithelial cells. Exp. Eye Res. 2006, 82:588-596.
65. Li J., Shen J., Beuerman R.W. Expression of toll-like receptors in human limbal and conjunctival epithelial cells. Mol. Vis. 2007, 8:813-822.
66. Li H., Zhang J., Kumar A., et al. Herpes simplex virus 1 infection induces the expression of proinflammatory cytokines, interferons and TLR7 in human corneal epithelial cells. Immunology 2005, 117:167-176.
67. Li H., Zhang J., Kumar A., et al. Herpes simplex virus 1 infection induces the expression of proinflammatory cytokines, interferons and TLR7 in human corneal epithelial cells. Immunology 2006, 117:167-176.
68. Liesegang J. Herpes simplex virus epidemiology and ocular importance. Cornea 2001, 1-13.
69. Liesegang T.J., Melton L.J., Daly P.J., Ilstrup D.M. Epidemiology of ocular herpes simplex. Incidence in Rochester, Minn, 1950 through 1982. Arch. Ophthalmol. 1989, 107:1155-1159.
70. Liu Y., Kimura K., Yanai R., Chikama T., Nishida T. Cytokine, chemokine, and adhesion molecule expression mediated by MAPKs in human corneal fibroblasts exposed to poly(I: C). Invest. Ophthalmol. Vis. Sci. 2008, 49:3336-3344.
71. Magone M.T., Chan C.-C., Beck L., et al. Systemic or mucosal administration of immunostimulatory DNA inhibits early and late phases of murine allergic conjunctivitis. Eur. J. Immunol. 2000, 30:1841-1850.
72. Maltseva I.A., Fleiszig S.M.J., Evans D.J., et al. Exposure of human corneal epithelial cells to contact lenses in vitro suppresses the upregulation of human β-defensin-2 in response to antigens of Pseudomonas aeruginosa. Exp. Eye Res. 2007, 85:142-153.
73. Matsumoto M., Funami K., Tanabe M., et al. Subcellular localization of toll-like receptor 3 in human dendritic cells. J. Immunol. 2003, 171:3154-3162.
74. McNamara N.A., Van R., Tuchin O.S., et al. Ocular surface epithelia express mRNA for human beta defensin-2. Exp. Eye Res. 1999, 69:483-490.
75. Miller R.L., Meng T.C., Tomai M.A. The antiviral activity of toll-like receptor 7 and 7/8 agonists. Drug News Perspect. 2008, 21:69-87. (Review).
76. Miyazaki D., Liu G., Clark L., et al. Prevention of acute allergic conjunctivitis and late-phase inflammation with immunostimulatory DNA sequences. Invest. Ophthalmol. Vis. Sci. 2000, 41:3850-3855.
77. Netea M.G., Ferwerda G., van der Graaf C.A., Van der Meer J.W., Kullberg B.J. Recognition of fungal pathogens by toll-like receptors. Curr. Pharm. Des. 2006, 12:4195-4201. (Review).
78. Pachigolla G., Blomquist P., Cavanagh H.D. Microbial keratitis pathogens and antibiotic susceptibilities: a 5-year review of cases at an urban county hospital in north Texas. Eye Contact Lens 2007, 33:45-49.
79. Pflugfelder S.C., Jones D., Ji Z., et al. Altered cytokine balance in the tear fluid and conjunctiva of patients with Sjögren's syndrome keratoconjunctivitis sicca. Curr. Eye Res. 1999, 19:201-211.
80. Radek K., Gallo R. Antimicrobial peptides: natural effectors of the innate immune system. Semin. Immunopathol. 2007, 29:27-43.
81. Redfern R.L., Reins R.Y., McDermott A.M. Toll-like receptors and antimicrobial peptide expression at the ocular surface. Invest. Ophthalmol. Vis. Sci. 2006, 47. E-abstract 4372.
82. Redfern R.L., Baxter J.A., Reins R.Y., et al. Toll-like receptor expression is modulated during dry eye conditions in vitro. Invest. Ophthlamol. Vis. Sci. 2007, 48. E-abstract 3651.
83. Roeder A., Kirschning C.J., Rupec R.A., Schaller M., Weindl G., Korting H.C. Toll-like receptors as key mediators in innate antifungal immunity. Med. Mycol. 2004, 42:485-498.
84. Sarangi P.P., Kim B., Kurt-Jones E., Rouse B.T. Innate recognition network driving herpes simplex virus-induced corneal immunopathology: role of the toll pathway in early inflammatory events in stromal keratitis. J. Virol. 2007, 81:11128-11138.
85. Schein O.D., McNally J.J., Katz J., Chalmers R.L., Tielsch J.M., Alfonso E., Bullimore M., O'Day D., Shovlin J. The incidence of microbial keratitis among wearers of a 30-day silicone hydrogel extended-wear contact lens. Ophthalmology 2005 Dec, 112(12):2172-2179.
86. Sloop G.D., Moreau J.M., Conerly L.L., Dajcs J.J., O'Callaghan R.J. Acute inflammation of the eyelid and cornea in Staphylococcus keratitis in the rabbit. Invest. Ophthalmol. Vis. Sci. 1999, 40:385-391.
87. Solomon A., Dursun D., Liu Z., et al. Pro-and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease. Invest. Ophthalmol. Vis. Sci. 2001, 42:2282-2292.
88. Song P.I., Abraham T.A., Park Y., et al. The expression of functional LPS receptor proteins CD14 and toll-like receptor 4 in human corneal cells. Invest. Ophthalmol. Vis. Sci. 2001, 42:2867-2877.
89. Spachidou M.P., Bourazopoulou E., Maratheftis C.I., et al. Expression of functional toll-like receptors by salivary gland epithelial cells: increased mRNA expression in cells derived from patients with primary Sjögren's syndrome. Clin. Exp. Immunol. 2007, 147:497-503.
90. Sun Y., Hise A.G., Kalsow C.M., Pearlman E. Staphylococcus aureus-induced corneal inflammation is dependent on toll-like receptor 2 and myeloid differentiation factor 88. Infect. Immun. 2006, 74:5325-5332.
91. Sun Y., Chandra J., Mukherjee P.K., Szczotka-Flynn L., Ghannoum M., Pearlman E. A murine model of contact lens associated Fusarium keratitis. Invest. Ophthalmol. Vis. Sci. 2009, First published as. 10.1167/iovs.09-4237.
92. Tabeta K., Georgel P., Janssen E., et al. Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:3516-3521.
93. Takeda K., Takeuchi O., Akira S. Recognition of lipopeptides by toll-like receptors. J. Endotoxin Res. 2002, 8:459-463.
94. Talreja J., Dileepan K., Puri S., et al. Human conjunctival epithelial cells lack lipopolysaccharide responsiveness due to deficient expression of MD2 but respond after interferon-γ priming or soluble MD2 supplementation. Inflammation 2005, 29:170-181.
95. Tsan M.F., Gao Baochong Pathogen-associated molecular pattern contamination as putative endogenous ligands of toll-like receptors. J. Endotoxin Res. 2007, 13:6-14. (Review).
96. Tuli S.S., Iyer S.A., Driebe W.T. Fungal keratitis and contact lenses: an old enemy unrecognized or a new nemesis on the block?. Eye Contact Lens 2007, 33:415-417.
97. Ueta M., Nochi T., Jang M.H., Park E.J., Igarashi O., Hino A., Kawasaki S., Shikina T., Hiroi T., Kinoshita S., Kiyono H. Intracellularly expressed TLR2s and TLR4s contribution to an immunosilent environment at the ocular mucosal epithelium. J. Immunol. 2004, 173:3337-3347.
98. Ueta M., Hamuro J., Kiyono H., et al. Triggering of TLR3 by polyI: C in human corneal epithelial cells to induce inflammatory cytokines. Biochem. Biophys. Res. Commun. 2005, 331:285-294.
99. von Aulock S., Morath S., Hareng L., et al. Lipoteichoic acid from Staphylococcus aureus is a potent stimulus for neutrophil recruitment. Immunobiology 2003, 208:413-422.
100. Vivino F.B., Minerva P., Huang C.H., et al. Corneal melt as the initial presentation of primary Sjögren's syndrome. J. Rheumatol. 2001, 28:379.
101. Wu X., Gao J., Ren M. Expression profiles and function of toll-like receptors in human corneal epithelia. Chin. Med. J. 2007, 120:893-897.
102. Wu M., McClellan S.A., Barrett R.P., Hazlett L.D. Beta-defensin-2 promotes resistance against infection with P. aeruginosa. J. Immunol. 2009, 182:1609-1616.
103. Wu M., McClellan S.A., Barrett R.P., Zhang Y., Hazlett L.D. Beta-defensins 2 and 3 together promote resistance to Pseudomonas aeruginosa keratitis. J. Immunol. 2009, 183:8054-8060.
104. Yamagami S., Yokoo S., Amano S., et al. Characterisation of bone marrow derived cells in the substantia propria of the human conjunctiva. Invest. Ophthalmol. Vis. Sci. 2007, 48:4476-4481.
105. Zhang J., Xu K., Ambati B., et al. Toll-like receptor 5-mediated corneal epithelial inflammatory responses to Pseudomonas aeruginosa flagellin. Invest. Ophthalmol. Vis. Sci. 2003, 44:4247-4254.
106. Zhang J., Kumar A., Wheater M., Yu F.S. Lack of MD-2 expression in human corneal epithelial cells is an underlying mechanism of lipopolysaccharide (LPS) unresponsiveness. Immunol. Cell Biol. 2009, 87:141-148.
107. Zhao J., Wu X.Y., Yu F.S. Activation of toll-like receptors 2 and 4 in Aspergillus fumigatus keratitis. Innate Immun. 2009, 15:155-168.